This mini-review will discuss the recent advances concerning the role of apelin on energy metabolism particularly in pathophysiological situations (obesity, type 2 diabetes) and will try to establish a link between plasma apelin concentrations and metabolic diseases in humans. The gene discussed is APLN; the disease is obesity due to melanocortin 4 receptor deficiency.